Atorvastatin for Reduction of 28-day Mortality in COVID-19: RCT
NCT04952350
·
clinicaltrials.gov ↗
PHASE3
Phase
UNKNOWN
Status
220
Enrollment
OTHER
Sponsor class
Conditions
Covid19
SARS-CoV2 Infection
COVID-19 Pneumonia
Interventions
DRUG:
Atorvastatin 40 Mg Oral Tablet
OTHER:
Placebo
Sponsor
Mansoura University